A first-of-its-kind device for pancreatic cancer treatment has been approved by the U.S. Food and Drug Administration.

KLF5 appears to fuel pancreatic cancer metastasis by reprogramming epigenetic controls, offering a potential new therapeutic target.

New @hopkinskimmel research finds extra copies of chromosome 1q may drive the earliest stages of pancreatic cancer. › ...

Your pancreas may be small, but it is extremely important when it comes to keeping us healthy. Here are five signs that your ...

A newly discovered link between pancreatic cancer and neural signaling reveals a promising drug target that slows tumor ...

Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the ...

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a ...

Dr. Anju Goel, MD, MPH, is a public health consultant and physician with more than 10 years of experience in the California public health system. The pancreas is an organ that makes enzymes for ...

The overall risk of malignancy in pancreatic cysts may be as low as 0.5 to 1.5%, and the annual risk of progression is 0.5%. 7,15 Conversely, studies estimate that 15% of all pancreatic ...